Olaparib Real-world Utilization and Clinical Outcomes in France, Italy, and the UK

CompletedOBSERVATIONAL
Enrollment

342

Participants

Timeline

Start Date

January 7, 2021

Primary Completion Date

September 27, 2024

Study Completion Date

September 27, 2024

Conditions
Ovary Cancer
Interventions
DRUG

Olaparib

Olaparib

Trial Locations (55)

1012

Research Site, Bourg-en-Bresse

10128

Research Site, Torino

16132

Research Site, Genova

20133

Research Site, Milan

20141

Research Site, Milan

20162

Research Site, Milan

25000

Research Site, Besançon

33000

Research Site, Bordeaux

33081

Research Site, Aviano

33210

Research Site, Langon

35760

Research Site, Saint-Grégoire

37000

Research Site, Tours

37024

Research Site, Negrar

37175

Research Site, Chambray-lès-Tours

38000

Research Site, Grenoble

40138

Research Site, Bologna

41124

Research Site, Modena

43126

Research Site, Parma

50134

Research Site, Florence

54000

Research Site, Nancy

59100

Research Site, Roubaix

62100

Research Site, Calais

69004

Research Site, Lyon

69310

Research Site, Pierre-Bénite

70021

Research Site, Acquaviva delle Fonti

70124

Research Site, Bari

74370

Research Site, Epagny Metz-Tessy

75014

Research Site, Paris

80131

Research Site, Napoli

84918

Research Site, Avignon

92150

Research Site, Suresnes

92210

Research Site, Saint-Cloud

94800

Research Site, Villejuif

95126

Research Site, Catania

09121

Research Site, Cagliari

00144

Research Site, Roma

00168

Research Site, Roma

Unknown

Research Site, Birmingham

Research Site, Cambridge

Research Site, Ediburgh

Research Site, Glasgow

Research Site, Guildford

Research Site, Leeds

Research Site, Liverpool

Research Site, Maidstone

Research Site, Manchester

Research Site, Newcastle

Research Site, Northampton

Research Site, Nottingham

Research Site, Portsmouth

Research Site, Swansea

EC1A7BE

Research Site, London

NW12BU

Research Site, London

SW36JJ

Research Site, London

W120HS

Research Site, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY